Immunodiagnostic Systems (IDS) Email Format

Medical Equipment ManufacturingEngland, United Kingdom501-1000 Employees

Immunodiagnostic Systems (IDS) provides in vitro diagnostic solutions to the clinical laboratory market. It develops, manufactures and markets immunoassays and automated immunoanalyser technologies, with a focus on endocrinology testing and related assay panels. Based in Boldon, in the North East of England, IDS operates as a mid-sized provider serving clinical laboratories and aiming to support accurate and efficient diagnostic workflows. 

In 2021, IDS was acquired by Revvity, Inc. and joined Euroimmun within Revvity’s diagnostics business; since then, it has been gradually integrated to broaden its product offerings and services for customers.

Sign up for free to view info

Company overview Employee directory